3 Canadian AI Healthcare Stocks With Revenue Growth Up To 53%
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report is about AI and big tech and pharma and health.
Directly affected
- No company is named in this report.
Indirectly affected
- QQQ Invesco QQQ-9.8% 30d
Invesco QQQ: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story.
- AIQ Global X Artificial Intelligence & Technology ETF-6.1% 11d
Global X Artificial Intelligence & Technology ETF: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- EWC iShares MSCI Canada ETF+2.0% 30d
iShares MSCI Canada ETF holds stocks listed in Canada, which this story is about (“canadian”).
- MSFT Microsoft+1.1% 30d
Microsoft (prepackaged software): big tech's AI spending and demand drive its shares. Linked by “ai” (AI and big tech) in this story.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- GOOGL Alphabet-15.7% 30d
Alphabet (computer programming, data processing, etc.): big tech's AI spending and demand drive its shares. Linked by “ai” (AI and big tech) in this story.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| QQQ | +3.12% | +5.08% | base | -1.35% | -0.76% | +0.17% | -5.59% |
| AIQ | +4.74% | +7.15% | base | -1.66% | -0.95% | -0.35% | -6.51% |
| XLV | -3.03% | -2.77% | base | +0.05% | -0.48% | +2.59% | +0.17% |
| EWC | +0.40% | +1.48% | base | +0.33% | -0.68% | +2.09% | -0.70% |
| MSFT | +2.03% | +1.97% | base | -2.87% | -0.22% | +6.53% | +2.62% |
| LLY | -9.71% | -8.92% | base | +0.15% | -0.54% | +0.07% | -3.00% |
| GOOGL | +13.19% | +16.25% | base | -0.31% | +0.00% | +3.25% | +0.97% |
| JNJ | -2.53% | -0.72% | base | -0.58% | -2.59% | +1.13% | -0.32% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
3 Canadian AI Healthcare Stocks With Revenue Growth Up To 53% Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| AIQ | that day | -1.66% | final price |
| AIQ | the next day | -0.95% | final price |
| AIQ | two days later | -0.35% | final price |
| AIQ | three days later | -6.51% | final price |
| AIQ | three days earlier | +7.15% | final price |
| AIQ | five days earlier | +4.74% | final price |
| EWC | that day | +0.33% | final price |
| EWC | the next day | -0.68% | final price |
| EWC | two days later | +2.09% | final price |
| EWC | three days later | -0.70% | final price |
| EWC | three days earlier | +1.48% | final price |
| EWC | five days earlier | +0.40% | final price |
| GOOGL | that day | -0.31% | final price |
| GOOGL | the next day | 0.00% | final price |
| GOOGL | two days later | +3.25% | final price |
| GOOGL | three days later | +0.97% | final price |
| GOOGL | three days earlier | +16.25% | final price |
| GOOGL | five days earlier | +13.19% | final price |
| JNJ | that day | -0.58% | final price |
| JNJ | the next day | -2.59% | final price |
| JNJ | two days later | +1.13% | final price |
| JNJ | three days later | -0.32% | final price |
| JNJ | three days earlier | -0.72% | final price |
| JNJ | five days earlier | -2.53% | final price |
| LLY | that day | +0.15% | final price |
| LLY | the next day | -0.54% | final price |
| LLY | two days later | +0.07% | final price |
| LLY | three days later | -3.00% | final price |
| LLY | three days earlier | -8.92% | final price |
| LLY | five days earlier | -9.71% | final price |
| MSFT | that day | -2.87% | final price |
| MSFT | the next day | -0.22% | final price |
| MSFT | two days later | +6.53% | final price |
| MSFT | three days later | +2.62% | final price |
| MSFT | three days earlier | +1.97% | final price |
| MSFT | five days earlier | +2.03% | final price |
| QQQ | that day | -1.35% | final price |
| QQQ | the next day | -0.76% | final price |
| QQQ | two days later | +0.17% | final price |
| QQQ | three days later | -5.59% | final price |
| QQQ | three days earlier | +5.08% | final price |
| QQQ | five days earlier | +3.12% | final price |
| XLV | that day | +0.05% | final price |
| XLV | the next day | -0.48% | final price |
| XLV | two days later | +2.59% | final price |
| XLV | three days later | +0.17% | final price |
| XLV | three days earlier | -2.77% | final price |
| XLV | five days earlier | -3.03% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna sold Microsoft (MSFT) (held by a dependent child), worth $1,001 - $15,000 on 28 Oct 2026. That is 5 days before publication. Filed 5 Nov 2026. View the filing.
- Sen. Shelley M Capito sold Microsoft (MSFT) (held by a spouse), worth $1,001 - $15,000 on 21 Oct 2026. That is 12 days before publication. Filed 4 Nov 2026. View the filing.
- Sen. Sheldon Whitehouse sold Microsoft (MSFT) (held by a spouse), worth $1,001 - $15,000 on 15 Oct 2026. That is 18 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 1 days after publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 13 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. David J. Taylor bought Alphabet (GOOGL), worth $1,001 - $15,000 on 3 Nov 2026. That is 1 days after publication. Filed 12 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Alphabet (GOOGL) (held by a dependent child), worth $1,001 - $15,000 on 28 Oct 2026. That is 5 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold Alphabet (GOOGL), worth $15,001 - $50,000 on 14 Sep 2026. That is 49 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 26 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 33 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“3 Canadian AI Healthcare Stocks With Revenue Growth Up To 53%” scores 12 out of 100. The score uses 1 sources.